Evidence map›Paper›PMID 40807315›Full record

ArticleMolecules (Basel, Switzerland)2025

Anti-

So Yeong Jeong, Dong-Min Kang, Hyun-Jun Kim, Sang Won Yeon, Hak Hyun Lee, Min Hee Kim, Bang Yeon Hwang, Mi-Jeong Ahn, Mi Kyeong Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. International journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

So Yeong JeongCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Dong-Min KangCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 52828, Republic of Korea.ORCID 0000-0002-3190-792X
Hyun-Jun KimForest Medicinal Resources Research Center, National Institute of Forest Science, Yeongju 36040, Republic of Korea.ORCID 0000-0002-6452-7982
Sang Won YeonCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Hak Hyun LeeCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Min Hee KimCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Bang Yeon HwangCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.ORCID 0000-0002-4148-6751
Mi-Jeong AhnCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 52828, Republic of Korea.ORCID 0000-0002-1201-0746
Mi Kyeong LeeCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.ORCID 0000-0001-5814-2720

Funding

National Institute of Forest Science FP0400-2022-02-2024National Research Foundation of Korea 2022R1A2C1008081
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAnti-Inflammatory AgentsAtractylodesHelicobacter pyloriRhizomeSesquiterpenesAnimalsHumansLactonesMiceMicrobial Sensitivity TestsMolecular StructurePlant ExtractsAnti-Bacterial AgentsAnti-Inflammatory Agentsatractylenolide Iatractylenolide IIILactonesPlant ExtractsSesquiterpenesanti-Helicobacter pylorianti-inflammatoryatractylenolide IAtractylodes macrocephalasesquiterpene

Identifiers

PMID40807315
PMCPMC12348959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.